Blocking indolamine 2, 3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy. (4th November 2015) - Monjazeb, Arta M; Kent, Michael; Grossenbacher, Steven K; Murphy, William